This week, host Eve Younger, economics correspondent for Israel Times, interviews Noam Solomon – CEO and co-founder at Immunai.
Immunai is a biotechnology corporate operating to comprehensively map and decode the immune machine with single-cell biology and AI to make new healing discoveries, boost up drug building, and strengthen affected person results.
Noam will discuss how Immunai makes use of AI and device studying to make scientific developments, and give an explanation for what device studying is in laymans phrases. He’ll additionally give an explanation for what sort of crew is most fitted to stand the demanding situations of a posh, deep science downside like mapping human immunity.
Israeli Innovation is your go-to podcast for all issues to do with innovation in Israel. Sign up for Eve Younger as she delves into the guts of Israel’s tech and industry scenes and uncovers the groundbreaking concepts and visionary minds operating to form the long run. Sign up for her every week as she shines a focus on the newest tendencies and entrepreneurial spirit propelling Israel to the vanguard of worldwide innovation.
Concentrate right here, on Apple, Spotify, or anywhere you get your podcasts.
